Introduction
The pandemic of coronavirus diseases 19 (COVID-19), caused by the severe
acute respiratory syndrome novel virus (SARS-CoV-2), continues despite
initiation of the global vaccination1. Besides its
exhausting length and overwhelming burden, the number of reports of
patients with SARS-CoV-2 reinfection is increasing2-4. A systematic review of the literature estimated
the incidence rate of the recurrent SARS‑CoV‑2 positivity to be 14.8%5.
The majority of the case reports on this topic have described a more
severe clinical presentation for the reinfection compared to the initial
encounter. However, to the best of our knowledge, there is no report to
present a case of reinfection with a different clinical manifestation
from the initial episode.